{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:58:38Z","timestamp":1790423918675,"version":"4.1.0"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Plant Sci."],"abstract":"<jats:p>\n                    Immunization with recombinant glycoprotein-based vaccines is a promising approach to induce protective immunity against viruses. However, the complex biosynthetic maturation requirements of these glycoproteins typically necessitate their production in mammalian cells to support their folding and post-translational modification. Despite these clear advantages, the incumbent costs and infrastructure requirements with this approach can be prohibitive in developing countries, and the production scales and timelines may prove limiting when applying these production systems to the control of pandemic viral outbreaks. Plant molecular farming of viral glycoproteins has been suggested as a cheap and rapidly scalable alternative production system, with the potential to perform post-translational modifications that are comparable to mammalian cells. Consequently, plant-produced glycoprotein vaccines for seasonal and pandemic influenza have shown promise in clinical trials, and vaccine candidates against the newly emergent severe acute respiratory syndrome coronavirus-2 have entered into late stage preclinical and clinical testing. However, many other viral glycoproteins accumulate poorly in plants, and are not appropriately processed along the secretory pathway due to differences in the host cellular machinery. Furthermore, plant-derived glycoproteins often contain glycoforms that are antigenically distinct from those present on the native virus, and may also be under-glycosylated in some instances. Recent advances in the field have increased the complexity and yields of biologics that can be produced in plants, and have now enabled the expression of many viral glycoproteins which could not previously be produced in plant systems. In contrast to the empirical optimization that predominated during the early years of molecular farming, the next generation of plant-made products are being produced by developing rational, tailor-made approaches to support their production. This has involved the elimination of plant-specific glycoforms and the introduction into plants of elements of the biosynthetic machinery from different expression hosts. These approaches have resulted in the production of mammalian N-linked glycans and the formation of O-glycan moieties\n                    <jats:italic>in planta<\/jats:italic>\n                    . More recently, plant molecular engineering approaches have also been applied to improve the glycan occupancy of proteins which are not appropriately glycosylated, and to support the folding and processing of viral glycoproteins where the cellular machinery differs from the usual expression host of the protein. Here we highlight recent achievements and remaining challenges in glycoengineering and the engineering of glycosylation-directed folding pathways in plants, and discuss how these can be applied to produce recombinant viral glycoproteins vaccines.\n                  <\/jats:p>","DOI":"10.3389\/fpls.2020.609207","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:50:59Z","timestamp":1606956659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding"],"prefix":"10.3389","volume":"11","author":[{"given":"Emmanuel","family":"Margolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10930-019-09831-w","article-title":"Protein quality control in the endoplasmic reticulum.","volume":"38","author":"Adams","year":"2019","journal-title":"Prot. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1042\/bst20170394","article-title":"Harnessing post-translational modifications for next-generation HIV immunogens.","volume":"46","author":"Allen","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1056\/nejmc080834","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.","volume":"358","author":"Arnold","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/glycob\/cwy021","article-title":"Global aspects of viral glycosylation.","volume":"28","author":"Bagdonaite","year":"2018","journal-title":"Glycobiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/mabs.20996","article-title":"Marketing approval of mogamulizumab: a triumph for glyco-engineering.","volume":"4","author":"Beck","year":"2012","journal-title":"MAbs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.sbi.2017.03.008","article-title":"Structural principles controlling HIV envelope glycosylation.","volume":"44","author":"Behrens","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14789450.2017.1376658","article-title":"Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1.","volume":"14","author":"Behrens","year":"2017","journal-title":"Exp. Rev. Prot."},{"key":"B8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1128\/jvi.74.2.627-643.2000","article-title":"A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.","volume":"74","author":"Binley","year":"2000","journal-title":"J. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.pmbts.2014.10.004","article-title":"The evolution of HIV-1 interactions with coreceptors and mannose C-type lectin receptors.","volume":"129","author":"Borggren","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1586\/erv.10.83","article-title":"Plant glycans: friend or foe in vaccine development?","volume":"9","author":"Bosch","year":"2010","journal-title":"Exp. Rev. Vaccines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1128\/jvi.01344-08","article-title":"Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design.","volume":"82","author":"Bowden","year":"2008","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06121-4","article-title":"Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer.","volume":"9","author":"Cao","year":"2018","journal-title":"Nat. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.febslet.2015.07.021","article-title":"A sweet code for glycoprotein folding.","volume":"589","author":"Caramelo","year":"2015","journal-title":"FEBS Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/pbi.12906","article-title":"An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana.","volume":"16","author":"Castilho","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/glycob\/cwr009","article-title":"N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans.","volume":"21","author":"Castilho","year":"2011","journal-title":"Glycobiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36518","DOI":"10.1074\/jbc.m112.402685","article-title":"Engineering of sialylated mucin-type O-glycosylation in plants.","volume":"287","author":"Castilho","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"15923","DOI":"10.1074\/jbc.m109.088401","article-title":"In planta protein sialylation through overexpression of the respective mammalian pathway.","volume":"285","author":"Castilho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1104\/pp.114.250720","article-title":"Proteolytic and N-glycan processing of human alpha1-antitrypsin expressed in Nicotiana benthamiana.","volume":"166","author":"Castilho","year":"2014","journal-title":"Plant Physiol."},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.77","article-title":"Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents.","volume":"2","author":"Chang","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1128\/jvi.00361-07","article-title":"Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1091\/mbc.e11-03-0201","article-title":"Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of alpha1-antitrypsin.","volume":"22","author":"Chen","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.virol.2016.12.010","article-title":"Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins.","volume":"502","author":"Collar","year":"2017","journal-title":"Virology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1021\/pr401162k","article-title":"Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.","volume":"13","author":"Crispin","year":"2014","journal-title":"J. Proteome Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev-biophys-060414-034156","article-title":"Structure and immune recognition of the HIV glycan shield.","volume":"47","author":"Crispin","year":"2018","journal-title":"Annu. Rev. Biophys."},{"key":"B25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1467-7652.2008.00384.x","article-title":"Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.","volume":"6","author":"D\u2019Aoust","year":"2008","journal-title":"Plant Biotechnol. J."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-10-62","article-title":"Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins\u2013towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.","volume":"10","author":"Daskalova","year":"2010","journal-title":"BMC Biotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pbi.12783","article-title":"Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.","volume":"16","author":"Dennis","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"B29","article-title":"Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike.","author":"Derking","year":"2020","journal-title":"bioRxiv[Preprint]."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104881","article-title":"Iminosugars: a host-targeted approach to combat Flaviviridae infections.","volume":"184","author":"DeWald","year":"2020","journal-title":"Antiviral Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/bit.26498","article-title":"cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.","volume":"115","author":"Dey","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2016.00018","article-title":"Transient glyco-engineering to produce recombinant IgA1 with Defined N- and O-Glycans in Plants.","volume":"7","author":"Dicker","year":"2016","journal-title":"Front. Plant Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1046\/j.1432-1327.2001.02384.x","article-title":"Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants.","volume":"268","author":"Dirnberger","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.vaccine.2004.11.003","article-title":"Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming.","volume":"23","author":"Faye","year":"2005","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1046\/j.1365-313x.1997.12061411.x","article-title":"N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells.","volume":"12","author":"Fitchette-Laine","year":"1997","journal-title":"Plant J."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005016","article-title":"Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.","volume":"11","author":"Fusco","year":"2015","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/protein\/3.5.433","article-title":"Sequence differences between glycosylated and non-glycosylated Asn-X-Thr\/Ser acceptor sites: implications for protein engineering.","volume":"3","author":"Gavel","year":"1990","journal-title":"Prot. Eng."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1128\/jvi.03451-14","article-title":"Single-Chain Soluble BG505.SOSIP gp140 trimers as structural and antigenic mimics of mature closed HIV-1 Env.","volume":"89","author":"Georgiev","year":"2015","journal-title":"J. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1021\/bi00439a030","article-title":"Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins: carbon-13 NMR studies of ovine submaxillary mucin.","volume":"28","author":"Gerken","year":"1989","journal-title":"Biochemistry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00346","article-title":"Efficient N-glycosylation of the heavy chain tailpiece promotes the formation of plant-produced dimeric IgA.","volume":"8","author":"G\u00f6ritzer","year":"2020","journal-title":"Fronti Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1073\/pnas.1102664108","article-title":"Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid.","volume":"108","author":"Halim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1073\/pnas.91.3.913","article-title":"Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control.","volume":"91","author":"Hammond","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1038\/srep08003","article-title":"N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.","volume":"5","author":"Hamorsky","year":"2015","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz2686","article-title":"Multiple roles for HIV broadly neutralizing antibodies.","volume":"11","author":"Haynes","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1126\/science.1254990","article-title":"AIDS\/HIV. Host controls of HIV neutralizing antibodies.","volume":"344","author":"Haynes","year":"2014","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0092-8674(95)90395-x","article-title":"Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum.","volume":"81","author":"Hebert","year":"1995","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.139.3.613","article-title":"The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin.","volume":"139","author":"Hebert","year":"1997","journal-title":"J. Cell Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/pbi.12469","article-title":"Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals.","volume":"13","author":"Holtz","year":"2015","journal-title":"Plant Biotechnol. J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1586\/1744666x.2013.836060","article-title":"Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response.","volume":"9","author":"Hsu","year":"2013","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.virol.2011.11.023","article-title":"Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction.","volume":"423","author":"Huang","year":"2012","journal-title":"Virology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"12947","DOI":"10.1021\/jacs.7b03868","article-title":"Residues comprising the enhanced aromatic sequon influence protein N-Glycosylation efficiency.","volume":"139","author":"Huang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"B52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/pbi.13194","article-title":"In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants.","volume":"18","author":"Hurtado","year":"2020","journal-title":"Plant Biotechnol. J."},{"key":"B53","year":"2020","journal-title":"10\/8\/202017. Press release. iBio Provides Update on IBIO-"},{"key":"B54","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/pbi.12981","article-title":"CRISPR\/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking beta-1,2-xylose and core alpha-1,3-fucose.","volume":"17","author":"Jansing","year":"2019","journal-title":"Plant Biotechnol. J."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/pbi.12981","article-title":"Methods of modulating N-glycosylation site occupancy of plant-produced glycoproteins and recombinant glycoproteins","author":"Jarczowski","year":"2016"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1073\/pnas.1604371113","article-title":"Engineering of complex protein sialylation in plants.","volume":"113","author":"Kallolimath","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/glycob\/cwi077","article-title":"O-linked glycosylation in maize-expressed human IgA1.","volume":"15","author":"Karnoup","year":"2005","journal-title":"Glycobiology"},{"key":"B58","year":"2020","journal-title":"14.7.2020. Medicago Begins Phase i Clinical Trials for Its Covid-19 Vaccine Candidate."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1105\/tpc.013862","article-title":"The STT3a subunit isoform of the Arabidopsis oligosaccharyltransferase controls adaptive responses to salt\/osmotic stress.","volume":"15","author":"Koiwa","year":"2003","journal-title":"Plant Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/prot.24747","article-title":"Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.","volume":"83","author":"Kong","year":"2015","journal-title":"Proteins"},{"key":"B61","doi-asserted-by":"publisher","first-page":"35551","DOI":"10.1074\/jbc.m110.160101","article-title":"Structural basis of cyclophilin B binding by the calnexin\/calreticulin P-domain.","volume":"285","author":"Kozlov","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/82_2018_103","article-title":"Targeting glycans on human pathogens for vaccine design.","volume":"428","author":"Krumm","year":"2020","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015559","article-title":"Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza.","volume":"5","author":"Landry","year":"2010","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/pbi.12986","article-title":"Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever.","volume":"17","author":"Laughlin","year":"2019","journal-title":"Plant Biotechnol. J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/pbi.12301","article-title":"Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants.","volume":"13","author":"Le Mauff","year":"2015","journal-title":"Plant Biotechnol. J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"10793","DOI":"10.1074\/jbc.m110.178020","article-title":"Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana.","volume":"286","author":"Liebminger","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jbiotec.2013.11.007","article-title":"The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.","volume":"170","author":"Liu","year":"2014","journal-title":"J. Biotechnol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.aaf6638","article-title":"Plant-produced biopharmaceuticals: a case of technical developments driving clinical deployment.","volume":"353","author":"Lomonossoff","year":"2016","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2015.04.005","article-title":"Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry.","volume":"483","author":"Luo","year":"2015","journal-title":"Virology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41579-41020-00441-41573","article-title":"Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.","volume":"18","author":"Margolin","year":"","journal-title":"Nat. Rev. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2019.01378","article-title":"Production and immunogenicity of soluble plant-produced HIV-1 Subtype C envelope gp140 immunogens.","volume":"10","author":"Margolin","year":"2019","journal-title":"Front. Plant Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/pbi.12963","article-title":"Production of complex viral glycoproteins in plants as vaccine immunogens.","volume":"19","author":"Margolin","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/pbi.13369","article-title":"Co-expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants.","volume":"18","author":"Margolin","year":"","journal-title":"Plant Biotechnol. J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.tibtech.2020.03.004","article-title":"Engineering the plant secretory pathway for the production of next-generation pharmaceuticals.","volume":"38","author":"Margolin","year":"","journal-title":"Trends Biotechnol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/molecules20022229","article-title":"Human lectins and their roles in viral infections.","volume":"20","author":"Mason","year":"2015","journal-title":"Molecules"},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800238","article-title":"Chimaeric rift valley fever virus-like particle vaccine candidate production in nicotiana benthamiana.","volume":"14","author":"Mbewana","year":"2019","journal-title":"Biotechnol. J."},{"key":"B77","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/EBC20160003","article-title":"Protein quality control at the endoplasmic reticulum.","volume":"60","author":"McCaffrey","year":"2016","journal-title":"Essays Biochem."},{"key":"B78","year":"2019","journal-title":"1\/10\/2019. Press Release.Medicago\u2019s New Drug Submission Accepted for Scientific Review by Health Canada."},{"key":"B79","year":"2020","journal-title":"12\/3\/2020. Medicago Announces Production of a Viable Vaccine Candidate for Covid-19."},{"key":"B80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0014-5793(98)00525-0","article-title":"Alpha-glucosidase inhibitors as potential broad based anti-viral agents.","volume":"430","author":"Mehta","year":"1998","journal-title":"FEBS Lett."},{"key":"B81","article-title":"Co-expression of human chaperone proteins in plants for increased expression of heterologous polypeptides.","volume":"201","author":"Meyers","year":"2018","journal-title":"WO"},{"key":"B82","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10545-011-9337-1","article-title":"Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation.","volume":"34","author":"Mohorko","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10067-013-2336-x","article-title":"Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFalpha biologics in rheumatic diseases.","volume":"32","author":"Mok","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/47062","article-title":"Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells.","volume":"402","author":"Molinari","year":"1999","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.288.5464.331","article-title":"Chaperone selection during glycoprotein translocation into the endoplasmic reticulum.","volume":"288","author":"Molinari","year":"2000","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1128\/jvi.78.13.7274-7278.2004","article-title":"Influence of N-glycans on processing and biological activity of the nipah virus fusion protein.","volume":"78","author":"Moll","year":"2004","journal-title":"J. Virol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00242","article-title":"In planta glycan engineering and functional activities of IgE antibodies.","volume":"7","author":"Montero-Morales","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00081","article-title":"Advanced Plant-Based Glycan Engineering.","volume":"6","author":"Montero-Morales","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1271\/bbb.100884","article-title":"Reduction of plant-specific arabinogalactan-type O-glycosylation by treating tobacco plants with ferrous chelator 2,2\u2019-dipyridyl.","volume":"75","author":"Moriguchi","year":"2011","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-12-14","article-title":"Setting up a platform for plant-based influenza virus vaccine production in South Africa.","volume":"12","author":"Mortimer","year":"2012","journal-title":"BMC Biotechnol."},{"key":"B91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.copbio.2019.10.005","article-title":"Molecular Pharming for low and middle income countries.","volume":"61","author":"Murad","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chembiol.2015.06.017","article-title":"Enhanced aromatic sequons increase oligosaccharyltransferase glycosylation efficiency and glycan homogeneity.","volume":"22","author":"Murray","year":"2015","journal-title":"Chem. Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1104\/pp.110.168773","article-title":"Production of complex multiantennary N-glycans in Nicotiana benthamiana plants.","volume":"155","author":"Nagels","year":"2011","journal-title":"Plant Physiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/blood-2004-11-4267","article-title":"HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation.","volume":"105","author":"Neil","year":"2005","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1074\/jbc.m114.616409","article-title":"O-linked glycosylation of the mucin domain of the herpes simplex virus type 1-specific glycoprotein gC-1 is temporally regulated in a seed-and-spread manner.","volume":"290","author":"Norden","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1091\/mbc.10.8.2573","article-title":"ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin.","volume":"10","author":"Oliver","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"B97","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nsmb.2600","article-title":"Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.","volume":"20","author":"Pancera","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1467-7652.2012.00704.x","article-title":"Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants.","volume":"10","author":"Parsons","year":"2012","journal-title":"Plant Biotechnol. J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2016.03.008","article-title":"A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults.","volume":"168","author":"Pillet","year":"2016","journal-title":"Clin. Immunol."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216533","article-title":"Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and >\/=50 years old adults.","volume":"14","author":"Pillet","year":"2019","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1016\/j.vaccine.2015.09.065","article-title":"Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.","volume":"33","author":"Pillet","year":"2015","journal-title":"Vaccine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1467-7652.2011.00614.x","article-title":"Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice.","volume":"9","author":"Pinkhasov","year":"2011","journal-title":"Plant Biotechnol. J."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1101\/2020.1104.1107.023903","article-title":"Structural and functional analysis of a potent sarbecovirus neutralizing antibody.","author":"Pinto","year":"2020","journal-title":"bioRxiv[Preprint]."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.aaz3505","article-title":"Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.","volume":"366","author":"Ramirez","year":"2019","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2018.02.054","article-title":"Common features of enveloped viruses and implications for immunogen design for next-generation vaccines.","volume":"172","author":"Rey","year":"2018","journal-title":"Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1016\/j.vaccine.2009.01.120","article-title":"Plants as biofactories for the production of subunit vaccines against bio-security-related bacteria and viruses.","volume":"27","author":"Rigano","year":"2009","journal-title":"Vaccine"},{"key":"B107","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/74035","article-title":"Recognition of local glycoprotein misfolding by the ER folding sensor UDP-glucose:glycoprotein glucosyltransferase.","volume":"7","author":"Ritter","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058724","article-title":"Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.","volume":"8","author":"Rosenberg","year":"2013","journal-title":"PLoS One"},{"key":"B109","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.1073\/pnas.1703682114","article-title":"Interdomain conformational flexibility underpins the activity of UGGT, the eukaryotic glycoprotein secretion checkpoint.","volume":"114","author":"Roversi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B110","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cell.2008.11.047","article-title":"Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms.","volume":"136","author":"Ruiz-Canada","year":"2009","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"crossref","first-page":"4540.e4543","DOI":"10.1016\/j.celrep.2020.03.025","article-title":"Structure-based design of prefusion-stabilized filovirus glycoprotein trimers.","volume":"30","author":"Rutten","year":"2020","journal-title":"Cell Rep."},{"key":"B112","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1467-7652.2010.00507.x","article-title":"Plant-made vaccines for humans and animals.","volume":"8","author":"Rybicki","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"B113","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/imr.12481","article-title":"Native-like Env trimers as a platform for HIV-1 vaccine design.","volume":"275","author":"Sanders","year":"2017","journal-title":"Immunol. Rev."},{"key":"B114","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04272-y","article-title":"Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer.","volume":"9","author":"Sarkar","year":"2018","journal-title":"Nat. Commun."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1091\/mbc.e08-04-0354","article-title":"Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation.","volume":"19","author":"Schallus","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.plaphy.2015.04.010","article-title":"Characterization of plants expressing the human beta1,4-galactosyltrasferase gene.","volume":"92","author":"Schneider","year":"2015","journal-title":"Plant Physiol. Biochem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0968-0004(02)00004-x","article-title":"Lectin control of protein folding and sorting in the secretory pathway.","volume":"28","author":"Schrag","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.celrep.2015.03.047","article-title":"Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design.","volume":"11","author":"Sharma","year":"2015","journal-title":"Cell Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1099\/jgv.0.000404","article-title":"Mutational and functional analysis of N-linked glycosylation of envelope fusion protein F of Helicoverpa armigera nucleopolyhedrovirus.","volume":"97","author":"Shen","year":"2016","journal-title":"J. Gen. Virol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1128\/jvi.78.10.5414-5422.2004","article-title":"Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking.","volume":"78","author":"Shi","year":"2004","journal-title":"J. Virol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/pbi.12602","article-title":"Reduced paucimannosidic N-glycan formation by suppression of a specific beta-hexosaminidase from Nicotiana benthamiana.","volume":"15","author":"Shin","year":"2017","journal-title":"Plant Biotechnol. J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1242\/jcs.139584","article-title":"Glycosylation of closely spaced acceptor sites in human glycoproteins.","volume":"126","author":"Shrimal","year":"2013","journal-title":"J. Cell Sci."},{"key":"B123","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.01.056","article-title":"Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies.","volume":"30","author":"Silver","year":"2020","journal-title":"Cell Rep."},{"key":"B124","article-title":"Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications.","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV.","volume":"19","author":"Sok","year":"2018","journal-title":"Nat. Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1002\/j.1460-2075.1995.tb00093.x","article-title":"The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase.","volume":"14","author":"Sousa","year":"1995","journal-title":"EMBO J."},{"key":"B127","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/pbi.13207","article-title":"Engineering the interactions between a plant-produced HIV antibody and human Fc receptors.","volume":"18","author":"Stelter","year":"2020","journal-title":"Plant Biotechnol. J."},{"key":"B128","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/glycob\/cww023","article-title":"Plant protein glycosylation.","volume":"26","author":"Strasser","year":"2016","journal-title":"Glycobiology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev-arplant-042817-040331","article-title":"Protein Quality Control in the Endoplasmic Reticulum of Plants.","volume":"69","author":"Strasser","year":"2018","journal-title":"Annu. Rev. Plant Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","article-title":"Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.","volume":"6","author":"Strasser","year":"2008","journal-title":"Plant Biotechnol. J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/pbi.12475","article-title":"Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents.","volume":"13","author":"Streatfield","year":"2015","journal-title":"Plant Biotechnol. J."},{"key":"B132","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.celrep.2018.07.080","article-title":"Site-specific glycosylation of virion-derived HIV-1 env is mimicked by a soluble trimeric immunogen.","volume":"24","author":"Struwe","year":"2018","journal-title":"Cell Rep."},{"key":"B133","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.bbrc.2014.10.102","article-title":"Association of malectin with ribophorin I is crucial for attenuation of misfolded glycoprotein secretion.","volume":"454","author":"Takeda","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B134","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/pbi.12076","article-title":"A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles.","volume":"11","author":"Thuenemann","year":"2013","journal-title":"Plant Biotechnol. J."},{"key":"B135","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","first-page":"10958","DOI":"10.1128\/jvi.00870-14","article-title":"Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography.","volume":"88","author":"Tran","year":"2014","journal-title":"J. Virol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/1040841x.2016.1242868","article-title":"Iminosugars: promising therapeutics for influenza infection.","volume":"43","author":"Tyrrell","year":"2017","journal-title":"Crit. Rev. Microbiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"20298","DOI":"10.1074\/jbc.270.35.20298","article-title":"Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms.","volume":"270","author":"Wada","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1016\/j.vaccine.2014.08.079","article-title":"Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines.","volume":"32","author":"Ward","year":"2014","journal-title":"Vaccine"},{"key":"B140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike.","volume":"369","author":"Watanabe","year":"","journal-title":"Science"},{"key":"B141","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.","volume":"11","author":"Watanabe","year":"","journal-title":"Nat. Commun."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology.","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B143","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1073\/pnas.1803990115","article-title":"Structure of the Lassa virus glycan shield provides a model for immunological resistance.","volume":"115","author":"Watanabe","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B144","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1.","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.jmb.2017.06.015","article-title":"A perspective on the structural and functional constraints for immune evasion: insights from Influenza Virus.","volume":"429","author":"Wu","year":"2017","journal-title":"J. Mol. Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/pbi.12796","article-title":"Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice.","volume":"16","author":"Yang","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"B147","doi-asserted-by":"publisher","first-page":"13657","DOI":"10.1073\/pnas.1515464112","article-title":"An intrinsic mechanism of secreted protein aging and turnover.","volume":"112","author":"Yang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B148","doi-asserted-by":"publisher","first-page":"11911","DOI":"10.1074\/jbc.m111.312918","article-title":"Engineering mammalian mucin-type O-glycosylation in plants.","volume":"287","author":"Yang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B149","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1073\/pnas.1600996113","article-title":"Monoclonal antibody therapy for Junin virus infection.","volume":"113","author":"Zeitlin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B150","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00425-005-0206-8","article-title":"Sialic acid concentrations in plants are in the range of inadvertent contamination.","volume":"224","author":"Zeleny","year":"2006","journal-title":"Planta"},{"key":"B151","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B152","author":"Ziady","year":"2020","journal-title":"This is no April Fool\u2019s. British American Tobacco is trying to make a coronavirus vaccine."}],"container-title":["Frontiers in Plant Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpls.2020.609207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T03:37:19Z","timestamp":1618544239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpls.2020.609207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":152,"alternative-id":["10.3389\/fpls.2020.609207"],"URL":"https:\/\/doi.org\/10.3389\/fpls.2020.609207","relation":{},"ISSN":["1664-462X"],"issn-type":[{"value":"1664-462X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"article-number":"609207"}}